GeoVax Labs, Inc. (GOVX)
0.505
-0.05
(-8.60%)
USD |
NASDAQ |
Sep 03, 16:00
0.5202
+0.02
(+3.01%)
After-Hours: 20:00
GeoVax Labs Total Assets (Quarterly) : 4.643M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.643M |
| March 31, 2026 | 2.982M |
| December 31, 2025 | 49.26M |
| September 30, 2025 | 6.731M |
| June 30, 2025 | 5.350M |
| March 31, 2025 | 10.83M |
| December 31, 2024 | 8.156M |
| September 30, 2024 | 11.11M |
| June 30, 2024 | 4.095M |
| March 31, 2024 | 3.358M |
| December 31, 2023 | 9.283M |
| September 30, 2023 | 16.20M |
| June 30, 2023 | 21.25M |
| March 31, 2023 | 27.40M |
| December 31, 2022 | 31.35M |
| September 30, 2022 | 38.57M |
| June 30, 2022 | 33.24M |
| March 31, 2022 | 16.85M |
| December 31, 2021 | 11.80M |
| September 30, 2021 | 18.34M |
| June 30, 2021 | 19.82M |
| March 31, 2021 | 21.12M |
| December 31, 2020 | 10.39M |
| September 30, 2020 | 11.76M |
| June 30, 2020 | 0.9579M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8308M |
| December 31, 2019 | 0.4689M |
| September 30, 2019 | 0.8165M |
| June 30, 2019 | 0.3426M |
| March 31, 2019 | 0.4726M |
| December 31, 2018 | 0.6421M |
| September 30, 2018 | 0.6235M |
| June 30, 2018 | 0.3714M |
| March 31, 2018 | 0.8395M |
| December 31, 2017 | 0.4902M |
| September 30, 2017 | 0.4956M |
| June 30, 2017 | 0.99M |
| March 31, 2017 | 0.3037M |
| December 31, 2016 | 0.6102M |
| September 30, 2016 | 0.6752M |
| June 30, 2016 | 0.3391M |
| March 31, 2016 | 0.7965M |
| December 31, 2015 | 1.332M |
| September 30, 2015 | 1.998M |
| June 30, 2015 | 2.664M |
| March 31, 2015 | 3.359M |
| December 31, 2014 | 1.333M |
| September 30, 2014 | 1.053M |
| June 30, 2014 | 1.521M |
| March 31, 2014 | 2.173M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.882M |
| Shareholders Equity (Quarterly) | 1.761M |
| Debt to Equity Ratio | 0.1835 |
| Current Ratio | 1.539 |
| Net Debt Paydown Yield | -0.69% |